Erratum: Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States of America (2014) 111, 7 (2686-2691) DOI: 10.1073/pnas.1400419111)

Antonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, David Engel, Marjorie Poggi, Susan Van Den Berg, Sjoerd Van Den Berg, Oliver Soehnlein, Holger Winkels, Linda Beckers, Dirk Lievens, Ann Driessen, Pascal Kusters, Erik Biessen, Ruben Garcia-Martin, Anne Klotzsche Von Ameln, Marion Gijbels, Randolph Noelle, Louis Boon, Tilman HackengKlaus Martin Schulte, Aimin Xu, Gert Vriend, Sander Nabuurs, Kyoung Jin Chung, Ko Willems Van Dijk, Patrick C.N. Rensen, Norbert Gerdes, Menno De Winther, Norman L. Block, Andrew V. Schally, Christian Weber, Stefan R. Bornstein, Gerry Nicolaes, Triantafyllos Chavakis, Esther Lutgens

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number12
DOIs
StatePublished - Mar 25 2014

ASJC Scopus subject areas

  • General

Cite this

Chatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., Van Den Berg, S., Van Den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Ameln, A. K. V., Gijbels, M., Noelle, R., Boon, L., ... Lutgens, E. (2014). Erratum: Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States of America (2014) 111, 7 (2686-2691) DOI: 10.1073/pnas.1400419111). Proceedings of the National Academy of Sciences of the United States of America, 111(12). https://doi.org/10.1073/pnas.1403231111